Basic Information
LncRNA/CircRNA Name | C13orf25 |
Synonyms | MIR17HG, C13orf25, FGLDS2, LINC00048, MIHG1, MIRH1, MIRHG1, NCRNA00048, miR-17-92 |
Region | GRCh38_13:91347820-91354579 |
Ensemble | ENSG00000215417 |
Refseq | NR_027349 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | diffuse large B-cell lymphoma |
ICD-0-3 | NA |
Methods | qPCR, Northern blot etc. |
Sample | cell lines (OCI-Ly4, OCI-Ly7, OCI-ly8 etc.) |
Expression Pattern | up-regulated |
Function Description | As a result, we identified a novel gene, designated Chromosome 13 open reading frame 25 (C13orf25), which was overexpressed in B-cell lymphoma cell lines and diffuse large B-cell lymphoma patients with 13q31-q32 amplifications. |
Pubmed ID | 15126345 |
Year | 2004 |
Title | Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. |
External Links
Links for C13orf25 | GenBank HGNC NONCODE |
Links for diffuse large B-cell lymphoma | OMIM COSMIC |